| AGTHX | CSIEX | AGTHX / CSIEX | |
| Total Expense Ratio | 0.59 | 0.90 | 66% |
| Annual Report Gross Expense Ratio | 0.59 | 0.90 | 66% |
| Fund Existence | 52 years | 38 years | - |
| Gain YTD | 1.566 | 1.891 | 83% |
| Front Load | 6% | 5% | 110% |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 336B | 4.8B | 6,996% |
| Annual Yield % from dividends | 0.27 | 0.18 | 152% |
| Returns for 1 year | 9.74 | -11.26 | -87% |
| Returns for 3 years | 57.29 | -1.42 | -4,045% |
| Returns for 5 years | 21.12 | 3.87 | 546% |
| Returns for 10 years | 122.62 | 84.20 | 146% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HGHCX | 26.01 | 0.20 | +0.77% |
| Hartford Healthcare C | |||
| VFSNX | 283.92 | 1.23 | +0.44% |
| Vanguard FTSE All-Wld ex-US SmCp Idx Ins | |||
| BMSYX | 15.54 | 0.02 | +0.13% |
| MFS Blended Research Mid Cap Eq R6 | |||
| JHARX | 10.57 | 0.01 | +0.09% |
| JHancock Multi-Asset Absolute Return R2 | |||
| FESMX | 13.60 | N/A | N/A |
| First Eagle U.S. SMID Cap Opportunity I | |||